NCT03906474View on ClinicalTrials.gov

VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

February 14, 2019

Study Completion Date

February 14, 2019

Conditions
Malaria
Interventions
BIOLOGICAL

Blood-stage controlled human P. falciparum malaria infection

Volunteers will be challenged with malaria by administering a small amount of P. falciparum infected blood intravenously.

Trial Locations (1)

OX3 7LE

CCVTM, University of Oxford, Churchill Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03906474 - VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection | Biotech Hunter | Biotech Hunter